Main > A1. CORP. INDEX. K-Km > Kalorama Information C2 > 2005. 06.06.2005. BioGenerics

The world market for generic biopharmaceuticals has the potential to be $5.4 billion by 2008, assuming that a favorable regulatory environment evolves for these products, according to a study conducted last year by Kalorama Information, a life sciences market research firm. The market barely existed in 2004 and is expected to be worth just $73 million this year.




2005. 06.06.2005. BioGenerics's products
This section has no products